Depo-Provera, a commonly used injectable contraceptive, has been linked to an increased risk of meningiomas, which are a type of brain tumor. If you or someone you know has been diagnosed with a ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

The costs of an intracranial meningioma diagnosis can be substantial. Not only can this diagnosis lead to a lifetime of medical bills and other costs, but it can drastically reduce patients’ quality ...

The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...

MINNEAPOLIS, Jan. 15, 2025 /PRNewswire/ -- National personal injury law firm Pritzker Hageman has assembled an all-female legal team to pursue litigation on behalf of women who developed meningioma ...

According to the Centers for Disease Control and Prevention (CDC), as of 2017, 65.3% of women between the ages of 15 and 49 in the United States use a form of birth control. Of this population, 10.4% ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...

PITTSBURGH, Jan. 17, 2025 (GLOBE NEWSWIRE) -- A California woman has filed a class-action lawsuit claiming pharmaceutical giants Pfizer (PFE) and Viatris (VTRS), among others, manufactured and sold ...

The judge appointed Chris Seeger as lead counsel and co-leads Ellen Relkin and Bryan Aylstock. More than 70 lawsuits against Pfizer allege Depo-Provera, an injectable birth control, has been linked to ...

A study published on 29 June 2025 in international peer reviewed medical journal Expert Opinion on Drug Safety by Frey et al. has found that use of Pfizer’s Depo-Provera (DMPA) for more than one year ...